Literature DB >> 15981099

Assessment of tumor cell invasion factors in gliomatosis cerebri.

Christian Mawrin1, Thomas Schneider, Raimund Firsching, Falk R Wiedemann, Knut Dietzmann, Antje Bornemann, Bernd F M Romeike, Bernd Sellhaus, Andreas von Deimling.   

Abstract

Gliomatosis cerebri (GC) is a rare brain tumor characterized by widespread infiltration of large parts of the brain and sometimes even the spinal cord. To determine the cause of this extraordinary degree of brain invasion, we studied immunoexpression of factors associated with brain infiltration in low-grade and high-grade tumor samples from nine GC cases. We further determined the allelic status of the fibroblastic growth factor receptor 4 (FGFR4) gene at position 388 (arginine [Arg(388)] or glycine [Gly(388)]) in eighteen GC patients, because the presence of at least one Arg(388) allele has been suggested to favor tumor cell motility compared to tumor cells homozygeous for the Gly(388) allele. Immunohistochemical analyses showed that tumor samples from three GC cases expressed Tenascin-C, whereas six cases had CD44 - immunopositive tumor samples. Expression of MMP-9 was not observed in any of the nine GC patients. FGFR4 genotyping revealed the presence of the Arg(388) in 72% of the eighteen GC cases, a frequency similar to the one found in 21 common astrocytomas (71%). In tumor-free control DNA, the Arg(388) phenotype was present in 60%. These data indicate that CD44 expression might be related to the tumor infiltration in GC, and that patients suffering from GC or other common astrocytomas do not have a significantly increased frequency of the tumor cell motility-favoring Arg(388) FGFR4 allele.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981099     DOI: 10.1007/s11060-004-4206-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  36 in total

Review 1.  Matrix metalloproteinases and their biological function in human gliomas.

Authors:  S K Chintala; J C Tonn; J S Rao
Journal:  Int J Dev Neurosci       Date:  1999 Aug-Oct       Impact factor: 2.457

2.  Alterations of cell cycle regulators in gliomatosis cerebri.

Authors:  Christian Mawrin; Elmar Kirches; Regine Schneider-Stock; Carsten Boltze; Christian K Vorwerk; Andreas von Mawrin; Elmar Kirches; Regine Schneider-Stock; Carsten Boltze; Christian K Vorwerk; Andreas von Mawrin; Elmar Kirches; Regine Schneider-Stock; Carsten Boltze; Christian K Vorwerk; Andreas von Mawrin; Elmar Kirches; Regine Schneider-Stock; Carsten Boltze; Christian K Vorwerk; Andreas von Deimling; Gisela Stoltenburg-Didinge; Antje Bornemann; Bernd Romeike; Bernd Sellhaus; Knut Dietzmann
Journal:  J Neurooncol       Date:  2005-04       Impact factor: 4.130

3.  Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.

Authors:  Johan M Kros; P Zheng; Winand N M Dinjens; Janneke C Alers
Journal:  J Neuropathol Exp Neurol       Date:  2002-09       Impact factor: 3.685

Review 4.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

5.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.

Authors:  A Nakano; E Tani; K Miyazaki; Y Yamamoto; J Furuyama
Journal:  J Neurosurg       Date:  1995-08       Impact factor: 5.115

6.  Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo.

Authors:  R Sawaya; Y Go; A P Kyritisis; J Uhm; B Venkaiah; S Mohanam; Z L Gokaslan; J S Rao
Journal:  Biochem Biophys Res Commun       Date:  1998-10-20       Impact factor: 3.575

7.  Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study.

Authors:  A Ariza; D López; J L Mate; M Isamat; E Musulén; M Pujol; A Ley; J J Navas-Palacios
Journal:  Hum Pathol       Date:  1995-10       Impact factor: 3.466

8.  CD44 mediates human glioma cell adhesion and invasion in vitro.

Authors:  A Merzak; S Koocheckpour; G J Pilkington
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

9.  Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors.

Authors:  S Nagasaka; K K Tanabe; J M Bruner; H Saya; R E Sawaya; R S Morrison
Journal:  J Neurosurg       Date:  1995-05       Impact factor: 5.115

10.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.